Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy.

Wasim S El NekidyMooza Al AliEmna AbidiRania M El-LababidiDiaa AlrahmanyDavid P NicolauMohamad MootyFadi HijaziMuriel GhosnJihad Mallat

Published in: Antibiotics (Basel, Switzerland) (2024)

Our findings indicated that C/T and CZA did not significantly differ in achieving clinical cure in patients with MDR PSA infections undergoing RRT. Larger clinical trials are needed to confirm our findings.

Keyphrases

gram negative
multidrug resistant
patients undergoing
clinical trial
prostate cancer
acute kidney injury
klebsiella pneumoniae
radical prostatectomy
open label
escherichia coli